Point72 Hong Kong’s Integra LifeSciences IART Stock Holding History

Point72 Hong Kong’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,505	Closed	-$1.04M	–	816
2022 Q3	$1.04M	Buy	+24,505	New	+$1.26M	0.04%	547
2022 Q2	–	Sell	-3,858	Closed	-$248K	–	2139
2022 Q1	$248K	Buy	3,858 +1,441	+60%	+$94.9K	0.01%	891
2021 Q4	$162K	Buy	+2,417	New	+$164K	0.01%	1063
2020 Q3	–	Sell	-6,268	Closed	-$295K	–	1335
2020 Q2	$295K	Buy	+6,268	New	+$308K	0.03%	445
2020 Q1	–	Sell	-4,130	Closed	-$241K	–	1127
2019 Q4	$241K	Buy	4,130 +2,380	+136%	+$142K	0.06%	286
2019 Q3	$105K	Buy	+1,750	New	+$104K	0.03%	442
2019 Q1	–	Sell	-95	Closed	-$4K	–	1138
2018 Q4	$4K	Buy	+95	New	+$5.21K	﹤0.01%	654

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Point72 Hong Kong's IART Position: Q4 2022 in Review

Point72 Hong Kong sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 24,505 shares — an estimated $1.04M sold.

Point72 Hong Kong first reported a position in IART in Q4 2018 and held it in 7 quarters. The position peaked at $1.04M in Q3 2022. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

Point72 Hong Kong reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 24,505 Integra LifeSciences shares in Q4 2022, an estimated $1.04M.
Point72 Hong Kong first reported a position in Integra LifeSciences in Q4 2018 and held it in 7 quarters.
Point72 Hong Kong's Integra LifeSciences position peaked at $1.04M in Q3 2022.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.